This site is intended for health professionals only

PHE issue tuberculosis call to action

Public Health Engand (PHE) believe that a primary care based screening programme could help tackle the problem with tuberculosis (TB) in the UK. 

In a comment published in The Lancet today (18 October), the PHE TB lead said more investment is “urgently needed”. 

London has the highest rate of TB of any western European capital and the UK will have more TB cases than the USA within two years, if current trends continue. 

Professor Ibrahim Abubakar, head of PHE TB section, and senior author said: “We urgently need more investment into services for tuberculosis diagnosis, treatment and prevention, targeted at high-risk and hard-to-reach groups and delivered as part of a coordinated national tuberculosis-control strategy.”

Latest figures show 8,751 TB cases were reported in the UK in 2012, slightly lower than the 8,963 cases reported in 2011. As in previous years, almost three quarters of cases were in people born in countries where TB is more common.

Dr Paul Cosford, director for health protection and medical director at PHE, said: “TB is a major priority for PHE and we are working with key partners to oversee the development of a stronger national and local approach to TB control.

“We are determined to see a sustained reduction in TB, and will work tirelessly to implement evidence based national strategies and to support local partners in those areas where the burden is greatest.”

Lead author Dr Dominik Zenner, head of the PHE TB screening unit said, “While a programme to screen for active tuberculosis before arrival to the UK is already in place, it does not detect latent tuberculosis infection in at-risk groups such as immigrants living in the UK, disadvantaged and vulnerable communities, or people on immunosuppressive therapy.”

The PHE researchers suggest a pragmatic solution might be a quality-assured primary-care based screening programme. This would involve screening for latent TB among high risk groups - people aged 16-35 years, who entered the UK in the past five years from a country with an incidence of 150 cases per 100,000 or higher.